ArticleInternational journal of molecular sciences2025

HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations.

Italia Falcone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.